{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "O conceito de campo de canceriza\u00e7\u00e3o foi empregado, pela primeira vez, por Slaughter em 1953, estudando o tecido alterado peri-tumoral de carcinoma espinocelular, atrav\u00e9s da histopatologia. O conceito foi proposto para explicar o desenvolvimento de m\u00faltiplos tumores prim\u00e1rios e recorrentes na mesma \u00e1rea onde j\u00e1 havia altera\u00e7\u00f5es histopatol\u00f3gicas. Os \u00f3rg\u00e3os que apresentam campo de canceriza\u00e7\u00e3o, at\u00e9 hoje descritos s\u00e3o: cavidade oral, orofaringe, pulm\u00e3o, vulva, es\u00f4fago, c\u00e9rvix uterino, pele, mama, c\u00f3lon e bexiga. Os resultados obtidos a partir da biologia molecular sustentam o modelo de carcinog\u00eanese, onde um campo com c\u00e9lulas geneticamente alteradas t\u00eam papel fundamental. Uma importante implica\u00e7\u00e3o cl\u00ednica \u00e9 o fato de que campos com c\u00e9lulas mutadas geralmente permanecem ap\u00f3s a cirurgia para a remo\u00e7\u00e3o de um tumor prim\u00e1rio, podendo originar novos tumores, designados como segundo tumor prim\u00e1rio ou recorr\u00eancia local, dependendo do local exato e do intervalo entre a cirurgia e a detec\u00e7\u00e3o deste novo tumor. O desenvolvimento de campos com c\u00e9lulas mutadas \u00e9 considerado uma etapa cr\u00edtica na carcinog\u00eanese, com importante repercuss\u00e3o cl\u00ednica. Assim, o diagn\u00f3stico e tratamento das les\u00f5es malignas epiteliais deve abordar n\u00e3o somente o tumor isolado mas sim, todo o campo onde se desenvolveu. Neste artigo, revisamos aspectos importantes da etiopatogenia, cl\u00ednica, histopatologia e da terap\u00eautica do campo de canceriza\u00e7\u00e3o."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24173184",
  "DateCompleted": {
    "Year": "2014",
    "Month": "04",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1590/abd1806-4841.20132300",
      "S0365-05962013000500775"
    ],
    "Journal": {
      "ISSN": "1806-4841",
      "JournalIssue": {
        "Volume": "88",
        "Issue": "5",
        "PubDate": {
          "Year": "2013",
          "Season": "Sep-Oct"
        }
      },
      "Title": "Anais brasileiros de dermatologia",
      "ISOAbbreviation": "An Bras Dermatol"
    },
    "ArticleTitle": "Cutaneous field cancerization: clinical, histopathological and therapeutic aspects.",
    "Pagination": {
      "StartPage": "775",
      "EndPage": "786",
      "MedlinePgn": "775-86"
    },
    "Abstract": {
      "AbstractText": [
        "The concept of \"field cancerization\" was first introduced by Slaughter in 1953 when studying the presence of histologically abnormal tissue surrounding oral squamous cell carcinoma. It was proposed to explain the development of multiple primary tumors and locally recurrent cancer. Organ systems in which field cancerization has been described since then are: head and neck (oral cavity, oropharynx, and larynx), lung, vulva, esophagus, cervix, breast, skin, colon, and bladder. Recent molecular studies support the carcinogenesis model in which the development of a field with genetically altered cells plays a central role. An important clinical implication is that fields often remain after the surgery for the primary tumor and may lead to new cancers, designated presently as \"a second primary tumor\" or \"local recurrence,\" depending on the exact site and time interval. In conclusion, the development of an expanding pre-neoplastic field appears to be a critical step in epithelial carcinogenesis with important clinical consequences. Diagnosis and treatment of epithelial cancers should not only be focused on the tumor but also on the field from which it developed. The most important etiopathogenetic, clinical, histopathological and therapeutic aspects of field cancerization are reviewed in this article."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hospital das Clinicas, University of S\u00e3o Paulo Medical School, S\u00e3o PauloSP, Brazil."
          }
        ],
        "LastName": "Torezan",
        "ForeName": "Lu\u00eds Ant\u00f4nio Ribeiro",
        "Initials": "LA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Festa-Neto",
        "ForeName": "Cyro",
        "Initials": "C"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Spain",
    "MedlineTA": "An Bras Dermatol",
    "NlmUniqueID": "0067662",
    "ISSNLinking": "0365-0596"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Carcinogenesis"
    },
    {
      "QualifierName": [
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Carcinoma, Squamous Cell"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasms, Multiple Primary"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Skin Neoplasms"
    }
  ],
  "CoiStatement": "Conflict of interest: None"
}